EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY-NC-ND 4.0

Biofield therapies: Guidelines for reporting clinical trials

Richard Hammerschlag, Meredith L Sprengel, Ann L Baldwin

Complementary Therapies in Medicine · 2024-06 · 82 · 103011

DOI: 10.1016/j.ctim.2023.103011 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Complementary Therapies in Medicine, 2024-06. Verfasst von Richard Hammerschlag und 2 weiteren Autor:innen. Beteiligte Einrichtung: Consciousness and Healing Initiative, La Jolla, CA, USA; NOVA Institute for Health, Baltimore, MD, USA. Electronic address: richard@chi.is. Hauptthemen laut MEDLINE: Clinical Trials as Topic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A set of guidelines has been developed to help improve reporting of clinical trials of biofield therapies. The need for enhanced transparency when reporting trials of this family of integrative health practices, e.g., External Qigong, Healing Touch, Reiki and Therapeutic Touch, has been advocated in systematic reviews of these studies. The guidelines, called Biofield Therapies: Reporting Evidence Guidelines (BiFi REGs), supplement CONSORT 2010 by including details of the intervention protocols relevant to biofield therapy trials. BiFi REGs evolved through a draft document created by a core group, two rounds of a Delphi process with an international group of subject matter experts and two panels, meeting via Zoom, which included editors of complementary and integrative medicine journals. BiFi REGs comprises a 15-item Intervention checklist. Modifications of two other CONSORT topic areas are also proposed to enhance their relevance to trials of biofield therapies. Included for each item are an explanation, and exemplars of reporting from peer-reviewed published reports of biofield therapy trials. When used in conjunction with all other items from CONSORT 2010, we anticipate that BiFi REGs will expedite the peer review process for biofield therapy trials, facilitate attempts at trial replication and help to inform decision-making in the clinical practice of biofield therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clinical Trials as TopicHumansTherapeutic TouchResearch DesignGuidelines as Topic

Stichwörter der Autor:innen

Biofield therapiesBiofield therapy clinical trialsReporting guidelines

Autor:innen und Institutionen

  • Consciousness and Healing Initiative, La Jolla, CA, USA; NOVA Institute for Health, Baltimore, MD, USA. Electronic address: richard@chi.is.
  • Human Factors, Netherlands Organisation for Applied Scientific Research (TNO), Soesterberg, the Netherlands; Subtle Energy Collective, San Francisco, CA, USA.
  • Department of Physiology, University of Arizona, Tucson, AZ, USA.

Zitieren

APA

Hammerschlag, R., Sprengel, M. L., & Baldwin, A. L. (2024). Biofield therapies: Guidelines for reporting clinical trials. Complementary Therapies in Medicine, 82, 103011. https://doi.org/10.1016/j.ctim.2023.103011

Vancouver

Hammerschlag R, Sprengel ML, Baldwin AL. Biofield therapies: Guidelines for reporting clinical trials. Complementary Therapies in Medicine. 2024;82:103011. doi:10.1016/j.ctim.2023.103011

BibTeX
@article{Hammerschlag2024,
  author = {Hammerschlag, Richard and Sprengel, Meredith L and Baldwin, Ann L},
  title = {Biofield therapies: Guidelines for reporting clinical trials},
  journal = {Complementary Therapies in Medicine},
  year = {2024},
  volume = {82},
  pages = {103011},
  doi = {10.1016/j.ctim.2023.103011}
}
Kostenlos starten →